Amid claims weight-loss drug side effects are being underreported, one expert says GPs play a crucial role in identifying adverse events, despite criticisms of the process.

Its manufacturer has again asked the PBAC to recommend lowering the eligibility age of non-Indigenous Australians from 65 to 60.

The course will help GPs identify gambling-related harm in patients and support them with evidence-based approaches.

Dr Elly Goodsall shares why disillusion and a system that undervalues complex care has left her walking away from general practice.

With 20.6% of Australians ‘digitally excluded’, GPs must ensure efficiency doesn’t come at the cost of care, writes Dr Rob Hosking.

From career panels to rural experiences, students got a firsthand look at the diverse opportunities a general practice career can offer.

An evaluation found 419 GPs had applications granted by the end of 2025, with 11% of those working in rural and remote areas.

The Federal Government is funding a new clinical guideline aimed at caring for women experiencing menopause and perimenopause.

A major GP billing shake-up has been proposed as an MBS review backs a simpler Medicare schedule that could dramatically reshape the fee structure.

The DVA is reminding GPs to keep up to date with news and resources to support care provision for this patient cohort.

Existing FRACGP-RG holders can apply to have specialist registration in Rural Generalist Medicine recorded by AHPRA.

As auditors scrutinise the program, the college says political pressure to establish services quickly has impacted both patients and the healthcare workforce.

A GP-produced video is asking just that, aiming to embed the importance of work–life balance from the start of registrars’ careers.

The RACGP-hosted General Practice in Addiction Conference saw GPs discuss practical tools for compassionate, evidence-based care.

An expert has welcomed the removal of an ‘administrative and logistical barrier’ to GPs managing patients with PBS-subsidised hepatitis B and C medication.

As advances in diabetes management continue, two experts discuss what the new technology would mean for GPs and patients.

GP Dr Michael Bonning will begin the role in November, with emergency medicine specialist Dr Sarah Whitelaw named Vice President.

It will discuss proposed changes to PBS listings for atomoxetine and guanfacine, including to reduce specialist-only requirements.

The ‘extraordinary’ drug is now listed for advanced cholangiocarcinoma, ovarian cancer, Merkel cell carcinoma, and urothelial cancer.

Following a world-first trial involving 3400 GPs, researchers hope their findings will lead to updated treatment guidelines for managing older patients.